That's essential, due to the fact that the method a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and be efficient. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (last year). Now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was an advancement practically nobody noticed. However it's going to have extensive implications for curing disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be lots of financial investment opportunities in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (united arab emirates). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it pulled back maybe significantly prior to going greater - jeff brown biotech stock pick for 2020. I have actually been covering bitcoin for a long time now. Among the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were primarily informing readers. However that's not the huge question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. jeff brown investment prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are numerous terrific private business on the edge of hitting the general public markets And I've been dealing with a new way for you to invest even before these companies go public.
This opportunity has been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the details. Go right here to book your spot for complimentary.
Emma Walsh here, managing editor of the Journal. Regular Journal readers understand that tech isn't our usual beat (jeff brown 1 biotech company). And when it comes to tech investing, we leave it to the specialists. Thankfully, we have several such specialists in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing professionals we understand (jeff brown 2020 predictions). In fact, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and predict what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid development and creating incredible chances for investors. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. longtime readers. But despite what numerous readers might believe, this is a trend that's just getting started. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, an outstanding 250 million 5G-enabled devices were still offered.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (democratic republic). Losing 2 months of manufacturing and sales really affects the number of 5G gadgets are offered in the calendar year. When you think about all of that, offering 250 million systems is remarkable. More importantly, the delays brought on by the pandemic developed a heap of bottled-up need. Which demand is now going to be pressed into 2021. In fact, I anticipate that more than 500 million 5G devices will be delivered in 2021 - artificial intelligence. Which's not my only 5G forecast When I've talked about 5G in the past, I've explained its three various stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Stage Three, 5G services begin to be used (jeff bezos). That's when we begin to see applications operating on 5G networks. Think of things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage Three by this summer season. This begins something of a virtuous cycle: The majority of people do not really care about the innovation. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In truth, 5G is going to open up a suite of incredible applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment opportunities going forward will be massive. Stepping far from 5G, the next essential technology I predict in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it's one of the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not operate properly. CRISPR utilizes a comparable concept however with our hereditary code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For many years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And during that time, there were truly only three companies running in this area. But things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and providing extraordinary returns. This whole industry is efficiently a greenfield chance.
There's room for numerous companies to exist in this space. artificial intelligence. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or 3 more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things taking place at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software can precisely forecast the folding of a protein based entirely on its amino acid series with 92. 4% precision. That's crucial because the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has been a trial-and-error process. And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but several drug treatments produced using this innovation. This was among those advancements that nearly no one observed. However it's going to have profound implications for treating illness. And, of course, there will be plenty of financial investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps considerably prior to going higher. I've been covering bitcoin for a very long time now. One of the very first research reports I ever released was on bitcoin - black sea. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my recommendation. However at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However no one is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. brownstone research stock. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the info depends on date as of February 2021, however we might not independently validate this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like capability to select winning innovation stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an exceptional perspective on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares numerous of his best picks in the Near Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he successfully forecasted a few of the most significant financial occasions of the past twenty years. Although he doesn't appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it ideal each time, but Jeff Brown's precise forecasts have made him legions of dedicated fans. That says a lot about his ability. The Near Future Report is published by Brownstone Research, a prominent monetary research study publisher. Brownstone Research study offers numerous research study services with a wide range of specializations - toxic tech 5 tech darlings.
The business is also associated with Bonner & Partners, another well-respected research study publisher - brownstone research stock. On its site, Brownstone states its mission is to provide retail investors with professional-grade research study: "For too long, the very best investment research study has actually not been offered to private investors. It has actually been normally booked for financial investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown 1 biotech company. The mission of Brownstone Research is to make that type of proprietary research readily available to any financiers wanting to acquire an edge in the marketplaces. The objective is easy to deliver special and rewarding financial investment research study found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also serves as the company's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After decades of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you know even a little bit about the market, you understand that he has a track record as a King Midas of sorts. jeff brown stock picks 2021. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown believes S.A.V. second wave. might be "the most significant trend of the 2020s, and he's not alone. Inspect out these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying 2 innovative technologies: expert system and electric cars. Musk hopes the combination will help him develop the first fully-autonomous, self-driving automobiles ever. It's nothing brief of the vehicle market's Holy Grail. As you understand, electrical lorries and self-driving vehicle stocks have actually been big this year, however the Wall Street device has been big on buzz without much concrete result. In spite of an extreme increase in competitors over the previous few years, Brown still believes Musk has the very best possibility of putting it all together.
tech could be the magic string that connects it all together. S.A.V. represents Shared Autonomous Car, and it might be the future of transport. Basically, this innovation would enable you to rent your car as an autonomous, self-driving taxi when you're not using it. You just leave the cars and truck and press a button on an app that informs the automobile to "join the fleet." Next thing you understand, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a substantial piece of the earnings. It sounds ridiculous, but it could be closed than you think.